Direct reprogramming of fibroblasts into cardiomyocytes for cardiac regenerative medicine.
Cardiac fibroblasts play critical roles in maintaining normal cardiac function and in cardiac remodeling during pathological conditions such as myocardial infarction (MI). Adult cardiomyocytes (CMs) have little to no regenerative capacity; damaged CMs in the heart after MI are replaced by cardiac fibroblasts that become activated and transform into myofibroblasts, which preserves the structural integrity. Unfortunately, this process typically causes fibrosis and reduces cardiac function. Directly reprogramming adult cardiac fibroblasts into induced CM-like cells (iCMs) holds great promise for restoring heart function. Direct cardiac reprogramming also provides a new research model to investigate which transcription factors and microRNAs control the molecular network that guides cardiac cell fate. We review the approaches and characterization of in vitro and in vivo reprogrammed iCMs from different laboratories, and outline the future directions needed to translate this new approach into a practical therapy for damaged hearts.
Heart and Vascular Research Center, MetroHealth Campus of Case Western Reserve University, Cleveland, OH, USA; Gladstone Institute of Cardiovascular Disease, USA; Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA, USA.
Ji-Dong
JD
Fu
Deepak
D
Srivastava
D000818:Animals; D065150:Cellular Reprogramming; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009203:Myocardial Infarction / Q000378:metabolism / Q000628:therapy*; D032383:Myocytes, Cardiac / Q000378:metabolism*; D051381:Rats; D044968:Regenerative Medicine / Q000379:methods*